HEMOSTEMIX INCHEMOSTEMIX INCHEMOSTEMIX INC

HEMOSTEMIX INC

No trades
See on Supercharts
Market capitalization
‪4.36 M‬CAD
−0.040CAD
‪−5.24 M‬CAD
‪74.52 M‬
Beta (1Y)
0.20

About HEMOSTEMIX INC

CEO
Thomas A. Smeenk
Headquarters
Calgary
Founded
2006
FIGI
BBG0038N5RC6
Hemostemix, Inc. is a clinical-stage biotechnology company, which is focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. The firm's, ACP-01, lead clinical stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. The company was founded by Roger Bergersen and Thomas A. Smeenk in 2006 and is headquartered in Calgary, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HEM is 0.050 CAD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange HEMOSTEMIX INC stocks are traded under the ticker HEM.
HEMOSTEMIX INC is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
HEM stock is 0% volatile and has beta coefficient of 0.20. Check out the list of the most volatile stocks — is HEMOSTEMIX INC there?
Yes, you can track HEMOSTEMIX INC financials in yearly and quarterly reports right on TradingView.
HEM stock has fallen by 9.09% compared to the previous week, the month change is a 23.08% fall, over the last year HEMOSTEMIX INC has showed a 70.59% decrease.
HEM net income for the last quarter is ‪−257.24 K‬ CAD, while the quarter before that showed ‪−284.94 K‬ CAD of net income which accounts for 9.72% change. Track more HEMOSTEMIX INC financial stats to get the full picture.
Today HEMOSTEMIX INC has the market capitalization of ‪4.36 M‬, it has decreased by 12.70% over the last week.
No, HEM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HEM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEMOSTEMIX INC stock right from TradingView charts — choose your broker and connect to your account.
HEM reached its all-time high on Dec 24, 2014 with the price of 25.000 CAD, and its all-time low was 0.050 CAD and was reached on Mar 20, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEMOSTEMIX INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEMOSTEMIX INC stock shows the sell signal. See more of HEMOSTEMIX INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.